SPI
18.551,09
PKT
+155,85
PKT
+0,85
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.03.12 | Emmi neutral | Sarasin Research | |
| 29.03.12 | Holcim sell | ING | |
| 28.03.12 | Helvetia Baloise neutral | J.P. Morgan Cazenove | |
| 28.03.12 | Peach Property Group buy | SRC Research GmbH | |
| 27.03.12 | ABB (Asea Brown Boveri) outperform | Exane-BNP Paribas SA | |
| 27.03.12 | Nestlé hold | ING | |
| 27.03.12 | Helvetia Baloise buy | Sarasin Research | |
| 27.03.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 26.03.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 26.03.12 | Holcim neutral | Exane-BNP Paribas SA | |
| 26.03.12 | UBS overweight | Morgan Stanley | |
| 26.03.12 | Zurich Insurance kaufen | Die Actien-Börse | |
| 23.03.12 | Sika neutral | Sarasin Research | |
| 22.03.12 | Givaudan sell | Goldman Sachs Group Inc. | |
| 22.03.12 | Clariant sell | Goldman Sachs Group Inc. | |
| 22.03.12 | Avolta (ex Dufry) buy | ING | |
| 22.03.12 | Helvetia Baloise buy | Sarasin Research | |
| 22.03.12 | Kudelski sell | UBS AG | |
| 22.03.12 | Arbonia neutral | Sarasin Research | |
| 22.03.12 | Straumann neutral | Sarasin Research | |
| 21.03.12 | Novartis buy | Deutsche Bank AG | |
| 21.03.12 | Komax buy | UBS AG | |
| 21.03.12 | Rieter neutral | Sarasin Research | |
| 21.03.12 | Nestlé overweight | Morgan Stanley | |
| 21.03.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 20.03.12 | Nestlé hold | ING | |
| 20.03.12 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 20.03.12 | Nestlé outperform | Exane-BNP Paribas SA | |
| 20.03.12 | Swisscom neutral | Nomura | |
| 20.03.12 | Komax buy | Sarasin Research | |
| 20.03.12 | Forbo International buy | Sarasin Research | |
| 20.03.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 19.03.12 | UBS buy | Citigroup Corp. | |
| 19.03.12 | Nestlé reduce | Nomura | |
| 16.03.12 | Novartis buy | Sarasin Research | |
| 16.03.12 | ams-OSRAM kaufen | Erste Bank AG | |
| 16.03.12 | Roche outperform | Exane-BNP Paribas SA | |
| 16.03.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 15.03.12 | UBS hold | Commerzbank Corp. & Markets | |
| 15.03.12 | Bucher Industries neutral | Sarasin Research |